Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Автор: | Moreino, Shannon Sherwin |
---|---|
Інші автори: | Kabir, Eva Rahman |
Формат: | Project report |
Мова: | English |
Опубліковано: |
BRAC University
2018
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/9331 |
Схожі ресурси
-
Biologics and Biosimilars as Treatment Options for Psoriasis
за авторством: Moya, Amena Khatun
Опубліковано: (2023) -
Biosimilar in lymphoma treatment
за авторством: Tanisha, Mehrin Haque
Опубліковано: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
за авторством: Tabassum, Turana
Опубліковано: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
за авторством: Tania, Umme
Опубліковано: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)